Concepedia

Yeheng Zhu

YZ

11

Publications

553

Citations

10

H-Index

2000

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Yeheng Zhu is an author at Bristol-Myers Squibb (United States) specializing in natural sciences, drug discovery, and medicine.

Top concepts

Publications per year

2000–2022

11

Publications

11

Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)

Richard Sulsky, David R. Magnin, Yanting Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 150 citations · Full text

, , +6

Overcoming Limitations in Decarboxylative Arylation via Ag–Ni Electrocatalysis

Maximilian D. Palkowitz, Gabriele Laudadio, Simon Kolb et al. · Journal of the American Chemical Society · 2022 · 130 citations · Full text

Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy

Andrew K. Dilger, Kumar B. Pabbisetty, James R. Corte et al. · Journal of Medicinal Chemistry · 2021 · 93 citations · Full text

N-3-Substituted Imidazoquinazolinones:  Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction

David P. Rotella, Zhong Sun, Yeheng Zhu et al. · Journal of Medicinal Chemistry · 2000 · 45 citations · Full text

, , +10

Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series

Bruce A. Ellsworth, Ying Wang, Yeheng Zhu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 36 citations · Full text

, , +12

Rows per page

1–5 of 11